Eva Feldman is a stem cell researcher at the University of Michigan who has been a big advocate of human embryonic stem cell research over the last few years. She is currently part of clinical trial which is using stem cells from an aborted child in an attempt to treat patients with ALS (also known as Lou Gehrig's disease). She is also working on research to transform patients' cells into induced pluripotent stem cells which have the same properties as embryonic stem cells but don't require the destruction of human embryos and then using those cells to study the disease.
In a recent interview with AnnArbor.com Feldman admitted that using cells from a patient's own body would be better for the patient.
The planned research could compliment the work Feldman is doing. It would be better for the patient, she said, to bank his own stem cells for use in the regenerative treatment she is exploring.
FULL STORY
